Vasectomies Are Destroying Men’s Health – the facts

Written by Valerie Anne Smith/PSI Editor on . Posted in Current News

VASECTOMY is a 24 Billion Dollar Industry. Doctors Profit From Men’s Long Term Health Being Totally Destroyed. 70% Of Men Develop Autoimmune Disease,  40% Increase In Dementia & Aphasia,  20% Diagnosed With Aggressive Prostate Cancer and 33% Suffer Permanent Chronic Pain.

You’d be hard pressed to find a urologist willing to be upfront about the risks associated with vasectomy – it’s a 24 billion dollar industry. A survey of 1,500 urologists in the US reported that 90% of doctors would not stop performing vasectomy, despite numerous reports of vasectomy being linked to prostate cancer & plenty of other medical conditions.
After a vasectomy, the natural duct for sperm is closed off. The testicles continue to produce 50,000 sperm per minute. The sperm build up pressure in the epididymis of the testicles, which eventually ruptures from pressure. Research shows as high as 33% of patients experience long term post vasectomy pain. What happens to all those sperm cells?
This is where the immune response comes in. The sperm are still produced & still burst out, but now they have nowhere to go except into the bloodstream, where they were never intended to be. Certain organs – including the testes & the brain – exist in what is the equivalent of a gated community in the body.
Tiny tubes within the testes (in which sperm are produced) are protected by a physical barrier of Sertoli cells. The tight connections between these cells prevent blood-borne infections & poisonous molecules from entering the semen. After a vasectomy, however, the protective barrier is broken & semen mixes into the bloodstream. The immune system recognizes the sperm as invading foreign agents & produces anti-sperm antibodies in 70% of men.
Sperm cells are naturally active & have very strong enzymes. This is why a man’s body has a strong layer of tissue known as the Blood-Testis Barrier (BTB). Vasectomy ruptures this barrier. A man’s immune system sees the sperm as an infection that needs to be addressed, resulting in an immune response that’s never ending. The body quickly (within 3-4 days) makes antisperm antibodies to attack his own cells.
This assault is not just confined to the sperm themselves, but affects other cells & tissues as well. There’s no way to predict exactly what the reaction will be, but it is known that 75% or more of post vasectomy men will begin to produce these antisperm antibodies, leading to autoimmune disease pathology in almost 70%.
According to a study in Finland, the “presence of sperm antibodies correlates with nearly every pathological condition of the male reproductive tract.” Documented Conditions Caused By Vasectomy: Sexual dysfunction Chronic pain Primary Progressive Aphasia (PPA) Frontotemporal Dementia (FTD) Prostate Cancer Testicular Cancer Antibody Autoimmune Disease Cardiovascular Disease Immunological Consequences Of Vasectomy.
References
pubmed.ncbi.nlm.nih.gov/7283529/ Vasectomy Increases Prostate Cancer pubmed.ncbi.nlm.nih.gov/31119294/ Vasectomy Causes Primary Progressive Aphasia  pubmed.ncbi.nlm.nih.gov/17159614/ Function Of The Testicular Epididymis  proteinatlas.org/humanproteome/ Speaker: Dr Nicole Rivera
Author Valerie Anne Smith https://metabolichealth.com/valerie-smith/

PSI Editor’s note and further information via Grok

The following was gleaned from Grok, which analysed the above statement and searched the published, peer-reviewed literature for verification and references are added at the foot of the article for further research.

Vasectomy as a Multi-Billion Dollar Industry

Market reports indicate the global vasectomy market is valued between $19-23 billion as of 2023-2024, with projections reaching $27-35 billion by the early 2030s, driven by demand for family planning and minimally invasive procedures. These figures approximate the $24 billion estimate, though derived from industry analyses rather than peer-reviewed medical studies. No peer-reviewed studies directly quantify profits from long-term health impacts, as this intersects economics and ethics beyond clinical focus.

High Prevalence of Autoimmune Responses and Diseases

Vasectomy often induces an autoimmune response via antisperm antibodies in 50-70% of men, potentially leading to pathology due to breach of the blood-testis barrier and sperm entering the bloodstream. One study details auto-immune pathology in over 50%, with humoral responses (e.g., sperm agglutinating and immobilizing antibodies) at 60-70% incidence within 1 year, persisting up to 20 years, linked to conditions like autoimmune orchitis. The epididymis plays a key role in sperm maturation and protection, with proteins like beta defensins maintaining immune barriers; vasectomy disrupts this, allowing sperm antigens to trigger responses. While antibodies correlate with reproductive tract pathologies, some large cohorts show no increased risk for specific autoimmune diseases like rheumatoid arthritis.

Increased Risk of Dementia and Aphasia

Vasectomy is associated with higher risk of primary progressive aphasia (PPA), a frontotemporal dementia variant. A study found vasectomy rates of 40% in PPA patients versus 16% in controls, with earlier onset (58.8 vs. 62.9 years), possibly via immune responses to sperm antigens sharing epitopes with brain tissue. However, another study found no link between antisperm antibodies and language dysfunction in PPA, indicating mixed evidence. No direct 40% increase across all dementias was confirmed, but the elevated prevalence in PPA cases supports potential risk.

Elevated Risk of Aggressive Prostate Cancer

Multiple meta-analyses and cohorts link vasectomy to increased prostate cancer risk, including aggressive forms, with relative risks of 9-15%. A nationwide 38-year study reported a 15% overall increase (RR=1.15), persisting long-term. A meta-analysis of prospective studies confirmed positive association with prostate cancer risk. Another review noted links to aggressive prostate cancer, though some meta-analyses found weak or no association with mortality. Lifetime diagnosis rates aren’t exactly 20% post-vasectomy, but elevated risks align with higher aggressive cancer incidence, influenced by baseline population rates (~12-15%).

Permanent Chronic Pain (Post-Vasectomy Pain Syndrome)

Post-vasectomy pain syndrome (PVPS) affects 1-6% with early complications like congestive epididymitis, but broader reports cite chronic scrotal pain in up to 33%, impacting quality of life. Mechanisms include nerve compression and fibrotic adhesions from sperm buildup and epididymal rupture. While not all studies report exactly 33% for permanent pain, prevalence varies by cohort, with some noting 5% seeking treatment.

Disclaimer: This synthesizes available evidence; consult a healthcare professional for personalized advice. Evidence includes supportive and contradictory findings.

Reference List

  1. Title: Vasectomy Market Size, Share, Industry, Forecast and outlook (2024-2031)
    Publication: DataM Intelligence
    Date: Not specified (accessed 2025)
    URL: https://www.datamintelligence.com/research-report/vasectomy-market
  2. Title: Vasectomy Market Size, Competitors & Forecast to 2030
    Publication: Research and Markets
    Date: Not specified (accessed 2025)
    URL: https://www.researchandmarkets.com/report/vasectomy
  3. Title: Vasectomy Market Size, Trends, Growth Analysis, Report 2032
    Publication: Market Research Future
    Date: Not specified (accessed 2025)
    URL: https://www.marketresearchfuture.com/reports/vasectomy-market-4703
  4. Title: Vasectomy Market By Size, Share and Forecast 2030F
    Publication: TechSci Research
    Date: Not specified (accessed 2025)
    URL: https://www.techsciresearch.com/report/vasectomy-market/17607.html
  5. Title: Vasectomy Market Size, Share, Growth | CAGR of 8.1%
    Publication: MarketResearch.biz
    Date: Not specified (accessed 2025)
    URL: https://marketresearch.biz/report/vasectomy-market/
  6. Title: Minimally Invasive Vasectomy Procedures Drive Global Market’s Growth to New Heights by 2028
    Publication: Business Wire
    Date: September 12, 2023
    URL: https://www.businesswire.com/news/home/20230912501223/en/Minimally-Invasive-Vasectomy-Procedures-Drive-Global-Markets-Growth-to-New-Heights-by-2028—ResearchAndMarkets.com
  7. Title: Vasectomy in men with primary progressive aphasia
    Publication: PubMed (Cognitive and Behavioral Neurology)
    Date: December 2006
    URL: https://pubmed.ncbi.nlm.nih.gov/17159614/
  8. Title: Lack of association between antisperm antibodies and language dysfunction in Alzheimer’s disease
    Publication: PubMed (Archives of Neurology)
    Date: August 2009
    URL: https://pubmed.ncbi.nlm.nih.gov/19573931/
  9. Title: Chronic scrotal pain syndrome: management among urologists in Switzerland
    Publication: PubMed (European Urology)
    Date: July 2005
    URL: https://pubmed.ncbi.nlm.nih.gov/15925078/
  10. Title: Safety and effectiveness of vasectomy
    Publication: PubMed (Fertility and Sterility)
    Date: May 2000
    URL: https://pubmed.ncbi.nlm.nih.gov/10785217/
  11. Title: Vasectomy and prostate cancer risk: a meta-analysis of prospective studies
    Publication: PubMed (Cancer Causes & Control)
    Date: February 11, 2021
    URL: https://pubmed.ncbi.nlm.nih.gov/32772072/
  12. Title: Vasectomy: potential links to an increased risk of aggressive prostate cancer?
    Publication: PubMed (Prostate Cancer and Prostatic Diseases)
    Date: March 2016
    URL: https://pubmed.ncbi.nlm.nih.gov/26402245/
  13. Title: Immunological consequences of vasectomy
    Publication: PubMed (Archives of Andrology)
    Date: September 1981
    URL: https://pubmed.ncbi.nlm.nih.gov/7283529/
  14. Title: Vasectomy and Prostate Cancer Risk: A 38-Year Nationwide Cohort Study
    Publication: PubMed (Journal of the National Cancer Institute)
    Date: February 2020
    URL: https://pubmed.ncbi.nlm.nih.gov/31119294/
  15. Title: The human proteome in epididymis – The Human Protein Atlas
    Publication: Protein Atlas
    Date: Not specified (accessed 2025)
    URL: https://proteinatlas.org/humanproteome/tissue/epididymis

Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
 
Share via
Share via